microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production.
Dong J, He M, Li J, Pessentheiner A, Wang C, Zhang J, Sun Y, Wang WT, Zhang Y, Liu J, Wang SC, Huang PH, Gordts PL, Yuan ZY, Tsimikas S, Shyy JY.
Dong J, et al. Among authors: wang wt, wang sc, wang c.
JCI Insight. 2020 Dec 3;5(23):e143812. doi: 10.1172/jci.insight.143812.
JCI Insight. 2020.
PMID: 33119548
Free PMC article.